BaseSpace
Correlation
Engine-Public
Sign In
Register
Home
My Data
Bookmarks
Collaborations
Inbox
Import Your Data
QuickView
FAQ
What is QuickView?
What can my QuickView results tell me?
What are the sources for the General Info tab in QuickView?
More QuickView FAQs
Back to top
QuickView
Curated
Studies
Body
Atlas
Disease
Atlas
Pharmaco
Atlas
Knockdown
Atlas
Genetic
Markers
Pathway
Enrichment
Literature
Clinical
Trials
0
Meta-
Analysis
QuickView
Search sequence regions
(e.g.
Neocentromeres
,
Aspirin
,
rs2230926
,
ZBTB7A
,
cell-cell adhesion
,
Hepatitis
,
Neuron
)
Organisms
Chromosomes
Start
Stop
Homo Sapiens
Mus Musculus
Rattus Norvegicus
C. Elegans
D. Melanogaster
Saccharomyces Cerevisiae
QuickView
Go back to main search
Bookmark
Forward
QuickView
for
xeroderma pigmentosum D
Summary
General Info
Curated Studies
Most Correlated Studies
OMIM - Xeroderma pigmentosum
Mouse Phenotypes - Xeroderma pigmentosum
Skin fibroblasts and cervical cancer cells with deficient XPA treated with all-trans retinoic acid
OMIM - Congenital disorder
Explore Curated Studies Results
Literature
Most Relevant Literature
A novel role for ATR/Rad3 in G1 phase.
Inner nuclear membrane protein Lem2 facilitates Rad3-mediated checkpoint signaling under replication…
High-Resolution Mapping of Homologous Recombination Events in rad3 Hyper-Recombination Mutants in Ye…
Crystal structure of the Rad3/XPD regulatory domain of Ssl1/p44.
Cloning, characterization and analysis of the 5' regulatory region of zebrafish xpd gene.
Explore Literature Results
Clinical Trials
Most Relevant Clinical Trials
Xeroderma Pigmentosum Patient Experiences
Cancer Risk in Carriers of the Gene for Xeroderma Pigmentosum
T4N5 Liposome Lotion Compared With Placebo Lotion for Preventing Actinic Keratoses in Patients With …
Examination of Clinical and Laboratory Abnormalities in Patients With Defective DNA Repair: Xeroderm…
Comparing a Novel Phototherapy Kiosk to Oral Vitamin D Supplementation
Explore Clinical Trials Results
search
→
result
search
→
result
See more about this page
See complete FAQ